Loading clinical trials...
Loading clinical trials...
This study will assess the efficacy, safety and tolerability of increasing doses of GK Activator (2) in patients with type 2 diabetes whose condition has not been optimally controlled with one previou...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT06525259 · Diabetes Mellitus Type 2, Childhood-Onset
NCT05934409 · Diabetes Mellitus Type 2
NCT03821636 · Diabetes Mellitus Type 2 in Obese
NCT06957093 · Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)
Chandler, Arizona
Oviedo, Florida
Nampa, Idaho
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions